Live Breaking News & Updates on Pfizer Covid 19 Vaccine Indemnity

India, Pfizer seek to resolve dispute over COVID-19 vaccine indemnity
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects
Reuters | May 22, 2021 | Updated 08:16 IST
Pfizer and the Indian government are seeking to resolve tensions over a demand by the U.S. drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world s biggest markets, two sources told Reuters.
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries where its shots have already been widely used, including Britain and the United States. ....

United States , United Kingdom , New Delhi , Albert Bourla , Suchitra Ella , Indian Council Of Medical Research , Bharat Biotech , Indian Council , Medical Research , Covid 19 Vaccine , Covid 19 Vaccine Indemnity , Pfizer Covid 19 Vaccine , Pfizer Covid 19 Vaccine Indemnity , Johnson And , Moderna Covid 19 Vaccine , Johnson And Covid 19 Vaccine , Moderna Covid 19 Vaccine Indemnity , Johnson And C , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , சூச்சித்ர எல்லா , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , பாரத் பயோடெக் , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி ,